tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
PhaseBio Pharmaceuticals's activity chart (see below) currently has 30 price targets and 24 ratings on display.
Analysts average stock forecasts to be materialized ratio is 2.78% with an average time for these price targets to be met of 24.67 days.
Most recent stock forecast was given by from STIFEL on 28-Sep-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Oct-2021
$1
$0.96 (2400.00%)
3 years 11 months 17 days ago
(28-Sep-2022)
0/2 (0%)
$0.74 (284.62%)
Buy Since 10-Jul-2020
$15
$14.96 (37400.00%)
4 years 11 months 1 days ago
(13-Oct-2021)
0/2 (0%)
$11.06 (280.71%)
Buy Since 13-Nov-2018
$15
$14.96 (37400.00%)
5 years 2 months 28 days ago
(17-Jun-2021)
0/4 (0%)
$11.02 (276.88%)
Buy Since 12-Nov-2018
$10
$9.96 (24900.00%)
$12
6 years 20 days ago
(25-Aug-2020)
0/6 (0%)
$6.2 (163.16%)
Buy Since 12-Nov-2018
$11
$10.96 (27400.00%)
$14
6 years 2 months 4 days ago
(10-Jul-2020)
1/6 (16.67%)
$6.27 (132.56%)
148
What is PHAS (PhaseBio Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on PHAS (PhaseBio Pharmaceuticals)?
Which analyst has the most public recommendations on PHAS (PhaseBio Pharmaceuticals)?
Which analyst is the currently most bullish on PHAS (PhaseBio Pharmaceuticals)?
Which analyst is the currently most reserved on PHAS (PhaseBio Pharmaceuticals)?
